| Breast Cancer |
1 |
1 |
| Toxicology |
0 |
0.82 |
| Biologic Therapy |
0 |
0.79 |
| Antineoplastic Drug |
0 |
0.61 |
| Small Cell Lung Cancer |
0 |
0.51 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.46 |
| Lung Cancer |
0 |
0.45 |
| Breast |
0 |
0.4 |
| Cancer |
0 |
0.4 |
| Interstitial Lung Disease |
0 |
0.4 |
| Lung |
0 |
0.4 |
| Nausea |
0 |
0.4 |
| Genomic Medicine |
0 |
0.36 |
| Humanized Monoclonal Antibody |
0 |
0.32 |
| Healthcare and Medical Technology |
0 |
0.28 |
| Clinical Research |
0 |
0.24 |
| Cardiovascular Imaging |
0 |
0.16 |
| Chemotherapy |
0 |
0.16 |
| Steroids |
0 |
0.16 |
| Adenocarcinoma of the Gastroesophageal Junction |
0 |
0.11 |
| Epidermal Growth Factor Receptor |
0 |
0.11 |
| Hodgkin Lymphoma |
0 |
0.09 |
| Myocardial Infarction (MI) |
0 |
0.09 |
| Neutropenia |
0 |
0.09 |
| Pneumonia |
0 |
0.09 |
| Sepsis |
0 |
0.09 |
| Adenocarcinoma |
0 |
0.08 |
| Antibody Drug Conjugates |
0 |
0.08 |
| California |
0 |
0.08 |
| CT Scan |
0 |
0.08 |
| Dyspnea |
0 |
0.08 |
| Ejection Fraction |
0 |
0.08 |
| Fellowship |
0 |
0.08 |
| Fever |
0 |
0.08 |
| Imbalance |
0 |
0.08 |
| Infarction |
0 |
0.08 |
| Prophylaxis |
0 |
0.08 |
| Receptors |
0 |
0.08 |
| Sudden Infant Death Syndrome |
0 |
0.08 |